Literature DB >> 28112425

In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

N H Manamperi1, S Oghumu2, N Pathirana3, M V C de Silva4, W Abeyewickreme1, A R Satoskar5, N D Karunaweera6.   

Abstract

Cutaneous leishmaniasis in Sri Lanka is a newly established parasitic disease caused by the usually visceralizing Leishmania donovani. Skin lesions manifest as non-itchy, non-tender papules, nodules or ulcers. In situ cytokine expression provides clues for immunopathogenesis of this localized form of disease. Skin biopsies from 58 patients were analyzed for histological appearance and in situ cytokine expression of T-helper 1 (Th1) and T-helper 2 (Th2) cytokines, namely interferon (IFN)-γ, interleukin (IL)-12A, tumor necrosis factor (TNF)-α, IL-4 and IL-10 by real-time RT-PCR. Significant up-regulation of the Th1 cytokine IFN-γ and down-regulation of the Th2 cytokine IL-4 were seen in patients compared to healthy controls. Significantly elevated tissue expression of IFN-γ and TNF-α was seen in lesions that presented later than 6 months from the time of onset, while IL-4 expression was more prominent in lesions that responded poorly to antimony therapy. A prominent Th1 response appears to support resolving of lesions, whereas a Th2-biased milieu tends to favor poor responsiveness to antimony and delayed lesion healing in L. donovani infections in Sri Lanka.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  IFN-γ; IL-4; Sri Lanka; TNF-α; cell-mediated immunity; histopathology

Mesh:

Substances:

Year:  2017        PMID: 28112425      PMCID: PMC5354984          DOI: 10.1111/pim.12413

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  47 in total

1.  First report of mucosal tissue localisation of leishmaniasis in Sri Lanka.

Authors:  U S Rajapaksa; R L Ihalamulla; N D Karunaweera
Journal:  Ceylon Med J       Date:  2005-06

2.  Locally acquired visceral leishmaniasis in Sri Lanka.

Authors:  P H Abeygunasekara; Y J Costa; N Seneviratne; N Ratnatunga; M de S Wijesundera
Journal:  Ceylon Med J       Date:  2007-03

3.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

4.  Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.

Authors:  E Bourreau; G Prévot; R Pradinaud; P Launois
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

5.  T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.

Authors:  Rita C Bittar; Ricardo S Nogueira; Ricardo Vieira-Gonçalves; Vanessa Pinho-Ribeiro; Marise S Mattos; Manoel Paes Oliveira-Neto; Sergio G Coutinho; Alda M Da-Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2007-08       Impact factor: 2.743

Review 6.  Cytokines and their STATs in cutaneous and visceral leishmaniasis.

Authors:  Hannah E Cummings; Rashmi Tuladhar; Abhay R Satoskar
Journal:  J Biomed Biotechnol       Date:  2010-03-15

7.  Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.

Authors:  Sudipto Ganguly; Nilay Kanti Das; Moumita Panja; Shekhar Pal; Dolanchampa Modak; Mehebubar Rahaman; Sudeshna Mallik; Subhashis Kamal Guha; Netai Pramanik; Ramapada Goswami; Joyashree Nath Barbhuiya; Bibhuti Saha; Mitali Chatterjee
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

8.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

Authors:  James Alexander; Frank Brombacher
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

10.  American tegumentary leishmaniasis: correlations among immunological, histopathological and clinical parameters.

Authors:  Ana Luiza Grizzo Peres Martins; Jaison Antonio Barreto; José Roberto Pereira Lauris; Ana Claudia Grizzo Peres Martins
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

View more
  6 in total

1.  Humoral immunity in leishmaniasis - Prevention or promotion of parasite growth?

Authors:  Ricardo Goncalves; Stephen M Christensen; David M Mosser
Journal:  Cytokine X       Date:  2020-10-31

2.  An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India.

Authors:  Lovlesh Thakur; Priyanka Madaan; Aklank Jain; Vinay Shankar; Ajeet Negi; Shashi Bhushan Chauhan; Shyam Sundar; Om Prakash Singh; Manju Jain
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

3.  Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.

Authors:  K K G D U L Kariyawasam; A Selvapandiyan; H V Y D Siriwardana; A Dube; P Karunanayake; S A S C Senanayake; R Dey; S Gannavaram; H L Nakhasi; N D Karunaweera
Journal:  Parasitology       Date:  2017-11-08       Impact factor: 3.234

Review 4.  A Comprehensive Review of Cutaneous Leishmaniasis in Sri Lanka and Identification of Existing Knowledge Gaps.

Authors:  Anjalie Amarasinghe; Susiji Wickramasinghe
Journal:  Acta Parasitol       Date:  2020-02-12       Impact factor: 1.440

5.  Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.

Authors:  Lahiru Sandaruwan Galgamuwa; Buthsiri Sumanasena; Devika Iddawela; Susiji Wickramasinghe; Lalani Yatawara
Journal:  BMC Microbiol       Date:  2019-01-14       Impact factor: 3.605

6.  Histopathology of Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka.

Authors:  Harshima Wijesinghe; Nayana Gunathilaka; Saveen Semege; Nishantha Pathirana; Nuwani Manamperi; Chandu de Silva; Deepika Fernando
Journal:  Biomed Res Int       Date:  2020-05-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.